Literature DB >> 17709138

Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorized as unclassified (MDS/MPD-U) by WHO classification.

Laura Cannella, Massimo Breccia, Roberto Latagliata, Annamaria Frustaci, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17709138     DOI： 10.1016/j.leukres.2007.07.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  9 in total

1.  Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases.

Authors:  Huifang Jiang; Zhonglin Wu; L I Ren; Diehong Tao; Hongyan Tong
Journal:  Oncol Lett       Date:  2015-11-25       Impact factor: 2.967

2.  Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.

Authors:  Laura Palomo; Manja Meggendorfer; Stephan Hutter; Sven Twardziok; Vera Ademà; Irene Fuhrmann; Francisco Fuster-Tormo; Blanca Xicoy; Lurdes Zamora; Pamela Acha; Cassandra M Kerr; Wolfgang Kern; Jaroslaw P Maciejewski; Francesc Solé; Claudia Haferlach; Torsten Haferlach
Journal:  Blood       Date:  2020-10-15       Impact factor: 22.113

3.  MDS/MPN-Unclassifiable with t(X;17)(q28;q21) and KANSL1-MTCP1/CMC4 Fusion Gene.

Authors:  Peter Molony; Adam C Smith; Shamini Selvarajah; Ali Sakhdari
Journal:  Cytogenet Genome Res       Date:  2022-01-17       Impact factor: 1.636

4.  Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.

Authors:  Sa A Wang; Robert P Hasserjian; Patricia S Fox; Heesun J Rogers; Julia T Geyer; Devon Chabot-Richards; Elizabeth Weinzierl; Joseph Hatem; Jesse Jaso; Rashmi Kanagal-Shamanna; Francesco C Stingo; Keyur P Patel; Meenakshi Mehrotra; Carlos Bueso-Ramos; Ken H Young; Courtney D Dinardo; Srdan Verstovsek; Ramon V Tiu; Adam Bagg; Eric D Hsi; Daniel A Arber; Kathryn Foucar; Raja Luthra; Attilio Orazi
Journal:  Blood       Date:  2014-03-13       Impact factor: 22.113

Review 5.  Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms.

Authors:  Laura Palomo; Pamela Acha; Francesc Solé
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

6.  Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.

Authors:  Rashmi Kanagal-Shamanna; Attilio Orazi; Robert P Hasserjian; Daniel A Arber; Kaaren Reichard; Eric D Hsi; Adam Bagg; Heesun Joyce Rogers; Julia Geyer; Faezeh Darbaniyan; Kim-Anh Do; Kyle M Devins; Olga Pozdnyakova; Tracy I George; Paola Dal Cin; Patricia T Greipp; Mark J Routbort; Keyur Patel; Guillermo Garcia-Manero; Srdan Verstovsek; L Jeffrey Medeiros; Sa A Wang; Carlos Bueso-Ramos
Journal:  Mod Pathol       Date:  2021-11-13       Impact factor: 7.842

7.  Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy.

Authors:  C D DiNardo; N Daver; N Jain; N Pemmaraju; C Bueso-Ramos; C C Yin; S Pierce; E Jabbour; J E Cortes; H M Kantarjian; G Garcia-Manero; S Verstovsek
Journal:  Leukemia       Date:  2014-01-10       Impact factor: 11.528

8.  Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes.

Authors:  Xia Xiao; Xiaoyuan He; Qing Li; Wei Zhang; Haibo Zhu; Weihong Yang; Yuming Li; Li Geng; Hui Liu; Lijuan Li; Huaquan Wang; Rong Fu; Mingfeng Zhao; Zhong Chen; Zonghong Shao
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

Review 9.  Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review.

Authors:  Meifang Zhao; Jingnan Sun; Shanshan Liu; Hongqiong Fan; Yu Fu; Yehui Tan; Sujun Gao
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.